HIV-1 gp120
Reaktivität: Human Immunodeficiency Virus (HIV)
WB, IHC, EIA
Wirt: Ziege
Polyclonal
Peroxidase (POD)
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1.0 mg/mL
Reynard, Fatmi, Verrier, Bedin: "HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity." in: Virology, Vol. 324, Issue 1, pp. 90-102, (2004) (PubMed).